Evidence map›Paper›PMID 32471057›Full record

ArticleMolecules (Basel, Switzerland)2020

Modern Strategies for Heterocycle Synthesis.

Gianfranco Favi

Abstract readEditorial
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Heterocycles in Medicinal Chemistry III.Molecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Synthesis and crystal structure ofActa crystallographica. Section E, Crystallographic communications · 2024
    Article
  5. Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.International journal of molecular sciences · 2023
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gianfranco FaviDepartment of Biomolecular Sciences, Section of Chemistry and Pharmaceutical Technologies, University of Urbino "Carlo Bo", Via I Maggetti 24, 61029 Urbino (PU), Italy.ORCID 0000-0003-3112-819X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterocycles constitute the largest and most diverse family of organic compounds that have received extensive interest owing to their popularity in many natural products, pharmaceuticals, and materials [...].

Indexed as

Biological ProductsHeterocyclic CompoundsBiological ProductsHeterocyclic Compounds

Identifiers

PMID32471057
PMCPMC7321172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.